Hiroko Terasaki Selected Research

Cytokines

1/2020	Lamivudine Inhibits Alu RNA-induced Retinal Pigment Epithelium Degeneration via Anti-inflammatory and Anti-senescence Activities.
1/2017	Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroko Terasaki Research Topics

Disease

32	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 05/2002
25	Macular Edema 11/2019 - 04/2003
18	Retinal Degeneration 01/2022 - 09/2007
17	Retinal Detachment (Retinal Detachments) 12/2019 - 09/2003
15	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2021 - 07/2003
14	Retinal Vein Occlusion 10/2021 - 10/2009
14	Retinal Perforations 05/2021 - 12/2003
13	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2020 - 01/2012
13	Choroidal Neovascularization 01/2018 - 12/2003
10	Epiretinal Membrane (Epiretinal Membranes) 01/2020 - 05/2003
7	Polypoidal Choroidal Vasculopathy 12/2020 - 12/2003
6	Inflammation (Inflammations) 05/2022 - 01/2007
5	Geographic Atrophy 10/2021 - 01/2018
5	Cataract (Cataracts) 01/2021 - 07/2002
5	Atrophy 01/2020 - 09/2002
5	Retinal Diseases 10/2018 - 01/2011
5	Ischemia 05/2014 - 10/2010
4	Blindness (Hysterical Blindness) 01/2021 - 01/2016
4	Ocular Paraneoplastic Syndromes 12/2019 - 01/2011
4	Proliferative Vitreoretinopathy 07/2017 - 01/2017
4	Vitreous Detachment (Posterior Vitreous Detachment) 02/2005 - 07/2003
3	Neoplasms (Cancer) 05/2022 - 01/2011
3	Retinoschisis (Retinoschisis, Juvenile) 01/2021 - 11/2003
3	Hypertension (High Blood Pressure) 01/2021 - 10/2018
3	Burns 06/2019 - 05/2015
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 11/2015 - 05/2009
2	Cone-Rod Dystrophies 01/2020 - 01/2019
2	Edema (Dropsy) 10/2017 - 06/2014
2	Central Serous Chorioretinopathy 05/2017 - 01/2017
2	Necrosis 01/2017 - 07/2010
2	Vitreous Hemorrhage 01/2017 - 05/2003
2	Acute zonal occult outer retinopathy 08/2015 - 01/2014
2	Pathologic Neovascularization 02/2013 - 03/2011
2	Acute Retinal Necrosis Syndrome 01/2010 - 03/2004
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Myopia 05/2021
1	Retinal Vasculitis 03/2021
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2020

Drug/Important Bio-Agent (IBA)

73	Retinaldehyde (Retinal)IBA 05/2022 - 07/2002
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 09/2007
13	Bevacizumab (Avastin)FDA Link 05/2022 - 01/2007
12	afliberceptIBA 05/2022 - 11/2014
9	Rhodopsin (Visual Purple)IBA 01/2019 - 09/2009
6	Ranibizumab (Lucentis)FDA Link 01/2018 - 01/2015
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2017 - 06/2009
4	Fluorescein (Funduscein)FDA LinkGeneric 09/2017 - 04/2003
4	Fibrinolysin FDA Link 02/2015 - 12/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2021 - 03/2010
3	SteroidsIBA 03/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2020 - 01/2009
3	Malondialdehyde (Propanedial)IBA 02/2020 - 01/2016
3	Biological ProductsIBA 02/2020 - 03/2017
3	AntibodiesIBA 01/2020 - 02/2005
3	Interleukin-18 (Interleukin 18)IBA 01/2020 - 09/2014
3	Verteporfin (Visudyne)FDA Link 01/2018 - 09/2012
3	MicroRNAs (MicroRNA)IBA 07/2017 - 01/2016
3	C-Reactive ProteinIBA 12/2010 - 01/2007
2	brolucizumabIBA 05/2022 - 03/2021
2	Complementary DNA (cDNA)IBA 10/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 02/2020 - 02/2013
2	InflammasomesIBA 01/2020 - 01/2018
2	CytokinesIBA 01/2020 - 01/2017
2	Caveolin 1IBA 01/2020 - 01/2017
2	Transient Receptor Potential ChannelsIBA 12/2019 - 01/2014
2	AutoantibodiesIBA 12/2019 - 01/2014
2	Silicone OilsIBA 01/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 03/2004
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2013 - 10/2010
2	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 10/2010
2	EnzymesIBA 10/2010 - 02/2004
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2009 - 09/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022
1	AdiponectinIBA 01/2022
1	SolutionsIBA 03/2021
1	betamethasone sodium phosphate FDA LinkGeneric 03/2021
1	Prednisolone (Predate)FDA LinkGeneric 03/2021
1	NucleosidesIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	AntioxidantsIBA 02/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	caveolin-1 (82-101)IBA 01/2020

Therapy/Procedure

31	Vitrectomy 01/2021 - 05/2002
17	Therapeutics 03/2021 - 01/2007
15	Lasers (Laser) 10/2021 - 05/2011
12	Intravitreal Injections 11/2019 - 01/2007
11	Light Coagulation 06/2019 - 07/2003
8	Injections 03/2021 - 10/2009
6	Photochemotherapy (Photodynamic Therapy) 01/2018 - 09/2012
5	Scleral Buckling 05/2017 - 09/2003
4	Traction 01/2018 - 05/2003
3	Drug Therapy (Chemotherapy) 05/2022 - 04/2010
3	Intraocular Lenses (Intraocular Lens) 01/2017 - 04/2003
2	Transplantation 05/2021 - 01/2016
2	Glycemic Control 09/2017 - 07/2003
2	Lenses 01/2004 - 05/2003
1	Intravenous Infusions 05/2022